• The collaboration aims to create standardised, stabilised live microbiota-based formulations addressing bacterial vaginosis (BV), a common vaginal infection among women of reproductive age linked to increased risk of miscarriage, problems during pregnancy and fertility issues1,2,3

• The companies aim to leverage world-leading microbiome technology expertise to bring new therapeutics to this patient community and help more people build families

• The agreement builds on the existing collaboration between MyBiotics and Ferring in developing live microbiota-based therapeutics for women’s health

ST PREX, Switzerland & ROSEVILLE, Minn. & ROHOVOT, Israel-Wednesday 17 February 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Ferring Pharmaceuticals, Rebiotix Inc., a Ferring Company, and MyBiotics Pharma Ltd. today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bac ... Read more »

Tax benefit provided to the persons for bringing their money, gold, funds, and other capital market instruments held abroad, provided a large capital inflow to Turkey. With the new amendment, the application period was extended until June 30, 2021.

ISTANBUL-Wednesday 17 February 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- The legislation known as ‘Wealth Amnesty’ allows the legal entrance of the funds, gold, securities and other market capitals into Turkey, without being subject to tax, with the condition to be declared until June 30, 2021.

While there was 1% or 2% tax in the past applications, with the current law, applicants started to benefit from this practice with 0% tax advantage. Natural and legal persons who have reported their wealth abroad to a bank or brokerage house in Turkey until June 30, 2021, will benefit from Wealth Amnesty if they bring these assets to Turkey within the 3 months as of the date of declaration.

Bayram Tekce, Cha ... Read more »

An Aspirational Community Takes Root at Majid Al Futtaim’s Flagship Destination

Dubai, United Arab Emirates-Wednesday 17 February 2021 [ AETOS Wire ]

Majid Al Futtaim appoints UNEC as main contractor for the construction of Elan Neighbourhood.
Phases 1 and 2 of Elan Neighbourhood to be delivered in phases starting December 2022.
 

With the start of the year comes the seeding of a community, as work commences on the Elan neighbourhood at Tilal Al Ghaf, the landmark lifestyle destination by Majid Al Futtaim Communities.

The responsibility for realising Majid Al Futtaim’s vision for Elan has been handed to UNEC, an award-winning contractor, and the highly reputable Arif & Bintoak Consulting Architects and Engineers. The contract award for Phases 1, 2 and 3 of Elan comprises a total of 916 premium three- and four-bedroom townhouses with a total contract value of almost AED 583 million. The first homes in Elan will b ... Read more »

 Kaneka Eurogentec, a custom service and FDA inspected Contract Development and Manufacturing Organization (CDMO) received GMP accreditation by the Belgian ministry of health for the GMP manufacturing of messenger RNA (mRNA).

SERAING, Belgium-Wednesday 17 February 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Kaneka Eurogentec:

A new GMP facility for active pharmaceutical ingredient production

The new facility audited and accredited by Belgian Authorities will allow the production and the purification of up to 10 g scale ( up to 1 Million doses of vaccine) of RNA for use in human clinical trials and commercial supply, with potential for expansion.

Strengthening Eurogentec’s position as a leader in gene therapy

Dr. Lieven Janssens, Kaneka Eurogentec’s President and CEO, said, “Manufacturing GMP mRNA complements perfectly our ongoing GMP DNA manufacturing activities providing a one-stop-shop offering Plasmid DNA, lineariza ... Read more »

Newest version of the C3 AI Suite expands lineage, ML model development/operations, and multi-cloud support features for accelerated time-to-value

REDWOOD CITY, Calif.-Wednesday 17 February 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- C3 AI (NYSE:AI), a leading enterprise AI software provider, today announced the release of major enhancements to its enterprise AI application development platform and AI applications designed to further accelerate digital transformation. Over the past decade, C3 AI has invested continuously in the C3 AI® Suite, its open, secure, and multi-cloud enterprise AI platform that leverages a model-driven architecture, enabling end-to-end enterprise AI including data integration, model development, MLOps, application development, and model governance and maintenance.

The latest release – Version 7.17 – provides new capabilities to track and manage full lineage from data sources to application entities. In addition, the latest r ... Read more »

LONDON-Wednesday 17 February 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Smiths Detection, a global leader in threat detection and security screening technologies, today reports that its BioFlash® Biological Identifier is capable of detecting SARS-CoV-2 in the air following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

The tests were performed using live SARS-CoV-2 virus in a Biosafety Level 3 containment area at Fort Detrick, Maryland. The SARS-CoV-2 CANARY biosensor used in the BioFlash device demonstrated that it can quickly detect and identify the presence of low levels of aerosolized SARS-CoV-2.

The BioFlash® Biological Identifier is powered by CANARY® technology (a cell-based biosensor) and is combined with proprietary aerosol-collection techniques to provide rapid, sensitive and specific identification of biological-threat agents including viruses, toxins and bacteria.

“We ar ... Read more »

TOKYO-Wednesday 17 February 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) announces the release of JMS-T2000GC "AccuTOF(TM) GC-Alpha", the latest model of the successful AccuTOF(TM) GC series gas chromatograph – time-of-flight mass spectrometers, to be released in February 2021. This product is a GC-MS that represents a significant improvement in performance and functionality using two newly developed Key Technologies. The basic hardware performance has been greatly improved and a new generation of automated data analysis software is included in the standard configuration.

Main Features

Two new Key Technologies

Key Technology 1: New high-performance hardware

The JMS-T2000GC "AccuTOF(TM) GC-Alpha", the 6th generation of the successful AccuTOF(TM) GC series, achieves three times the mass resolving power and mass measurement accuracy of the previous "AccuTOF(TM) GCx-plus ... Read more »

WALLINGFORD, Conn.-Wednesday 17 February 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Nel Hydrogen Electrolyser, a subsidiary of Nel ASA (Nel, OSE:NEL), has launched the MC250 and MC500 containerized Proton PEM electrolysers.

“We are proud to officially launch the MC250 and MC500, representing automated MW-class on-site hydrogen generators utilizing a modular containerized design for ease of installation and integration. Nel is pleased to expand our product offering with additional two world-class hydrogen generators and we are already experiencing significant interest for these solutions in the market,” says Filip Smeets, SVP Electrolyser Division of Nel.

The containerized MC250 and MC500 will be delivered as standard 1.25 and 2.5 MW (246 and 492 Nm3/h) configurations respectively. The new products are integrating Nel’s newly developed 1.25 MW PEM cell-stack, allowing for higher capacities per unit and lower cost. The platform allows multiple uni ... Read more »